Biomaterials advances.

ISSN 2772-9508Elsevier LtdUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoMatched via identifier

Journal overview

Titles
Biomaterials Advances
Biomater. Adv. (abbreviated)
Biomaterials advances.
Biomater Adv (abbreviated)
ISSN
2772-9516
eISSN
2772-9508
NLM ID
9918383886206676
Publisher
Elsevier Ltd
[Amsterdam] : Elsevier B.V., [2022]-
Country
Language
ENG
English

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2022–2027
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
1.138
Best Quartile
Q1
H-index
212
Subject categories
  • Bioengineering — Q1
  • Biomaterials — Q1
  • Biomedical Engineering — Q1
More metrics
Coverage
2022–2026
Country
United Kingdom
Region
Western Europe
Publisher
Elsevier Ltd
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
311
Total documents (3 years)
1140
Total references
22449
Total citations (3 years)
8181
Citable documents (3 years)
1134
Citations per document (2 years)
6.85
References per document
72.18
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2772-9508
SCImago Source ID
21101091765
SCImago Rank (across all SCImago source types)
3958

Publication activity

Publication activity
2025
311 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Biocompatible Materials; Biomimetic Materials; Nanotechnology
Scopus:2022-2027
MEDLINE:MEDLINE: v133, Feb. 2022-In: PubMed: v133, Feb. 2022-;
PubMed:MEDLINE: v133, Feb. 2022-In: PubMed: v133, Feb. 2022-;